Business
AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
Appointment Supports AIML's Commercial Execution and Operational Scale as the Company Advances Its AI-Driven Cardiac Platform Leadership Addition Aligns Revenue, Delivery, and Product Execution as AIML Transitions from Innovation to Scale TORONTO, ...
About this update from Aiml Innovations Inc
[{"type":"list","items":[{"val":[{"type":"text","content":"Appointment Supports AIML's Commercial Execution and Operational Scale as the Company Advances Its AI-Driven Cardiac Platform","length":129,"tagName":"p"}]},{"val":[{"type":"text","content":"Leadership Addition Aligns Revenue, Delivery, and Product Execution as AIML Transitions from Innovation to Scale","length":112,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":241,"olType":false},{"type":"text","content":"TORONTO, ON / ACCESS Newswire / January 7, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company"), (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is pleased to announce the appointment of Erik Suokas as Chief Operating Officer, strengthening the Company's leadership team as it advances into its next phase of commercialization and scale.","length":351,"tagName":"p"},{"type":"text","content":"Mr. Suokas will oversee AIML's day-to-day operations and execution across commercial strategy, contract discipline, delivery readiness, and cross-functional alignment. He will work closely with Paul Duffy, Executive Chairman & Chief Executive Officer, and Esmat Naikyar, Chief Product Officer, to convert growing commercial momentum into repeatable revenue and scalable delivery.","length":387,"tagName":"p"},{"type":"text","content":"Purpose-Built Leadership for AIML's Next Phase","length":50,"tagName":"p"},{"type":"text","content":"AIML has reached a pivotal stage in its evolution - transitioning from platform development and validation into revenue execution, customer delivery, and operational scale. The appointment of a Chief Operating Officer reflects the Company's focus on pairing innovation with disciplined execution as it expands commercial relationships across clinical, wellness, and enterprise health markets.","length":396,"tagName":"p"},{"type":"text","content":"Mr. Suokas brings more than 20 years of leadership experience across healthcare, MedTech, SaaS, and regulated clinical environments, with a consistent track record of building teams, accelerating revenue, and operationalizing growth in complex, cross-border markets.","length":266,"tagName":"p"},{"type":"text","content":"Most recently, Mr. Suokas served as National Director at Sun Nuclear North America, a leading provider of quality assurance and software solutions for radiation oncology and medic...